Scrip's Five Must-Know Things - Aug. 10, 2026

Audio roundup of selected biopharma industry content from Scrip over the business week ended Aug. 7, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—Novo Nordisk weighs bolt-on deals; Bayer slams Germany pricing; Lilly soars despite Foundayo struggles; European biotech wants to leapfrog; and a look at the potential AstraZeneca/BMS combination in APAC.

Story links: insights.citeline.com/scrip/podcasts/scrips-fi…

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts (podcasts.apple.com/us/podcast/scrip-podcasts/i…), and Spotify Podcasts (open.spotify.com/show/54Ki1l5bTzuxvrUylwbvO9?s…)and on TuneIn (tunein.com/podcasts/Business--Economics-Podcas…).